Cite
HARVARD Citation
Cabezas-Camarero, S. et al. (2022). Durable benefit and change in TCR clonality with nivolumab in a Lynch syndrome–associated glioma. Therapeutic advances in medical oncology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cabezas-Camarero, S. et al. (2022). Durable benefit and change in TCR clonality with nivolumab in a Lynch syndrome–associated glioma. Therapeutic advances in medical oncology. p. . [Online].